get a key
steadybase-$ company ZVRA
account_id none on file
legal_name Zevra Therapeutics, Inc.
ticker ZVRA
cik 1434647
domain zevra.com
entry_point_account_id none on file
name Zevra Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Boston, MA, United States
calls 0 filings 4 executives 10 family 0
why_nownone on file
callsnone on file
filings
Building distributor network in select territories

ir_statement / Sep 16, 2026 / receipt

Geographic expansion to broaden access outside the U.S. and Europe

ir_statement / Sep 16, 2026 / receipt

Geographic expansion to broaden access to patients beyond U.S. and Europe

ir_statement / Sep 16, 2026 / receipt

Go to market strategy in Europe

ir_statement / Sep 16, 2026 / receipt

executives
Alicia Secor director - receipt
Christopher A. Posner director - receipt
Justin Renz Chief Financial Officer - receipt
Matthew R. Plooster Chairman of the Board - receipt
Neil F. McFarlane President and Chief Executive Officer - receipt
R. LaDuane Clifton Chief Financial Officer - receipt
Richard W. Pascoe Chief Executive Officer - receipt
Tamara A. Seymour director - receipt
Thomas Anderson director - receipt
Timothy J. Sangiovanni Vice President - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2026-03-09 Chief Financial Officer, appointed sec_8k
2025-12-02 director, appointed sec_8k
2023-10-10 President and Chief Executive Officer, appointed sec_8k
2023-08-07 director, appointed sec_8k
2023-01-09 Chairman of the Board, appointed sec_8k
2023-01-09 Chief Executive Officer, appointed sec_8k
2022-11-29 director, appointed sec_8k
2021-08-18 director, appointed sec_8k
2017-02-15 Vice President, appointed sec_8k
2015-06-26 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$